Y2ATRACEMI Tablets

Adult dose

Children over 12 years and adults It is recommended to administer an initial dose of 4 tablets, with subsequent dosing intervals of at least 6 hours, ensuring not to exceed 16 tablets in 1 day. The lowest effective dose should be given for the shortest possible duration. Avoid prolonged administration beyond what is necessary; if prolonged use is required due to the nature and severity of the condition, regular monitoring should be conducted.

Child dose

Children over 12 years and adults It is recommended to administer an initial dose of 4 tablets, with subsequent dosing intervals of at least 6 hours, ensuring not to exceed 16 tablets in 1 day. The lowest effective dose should be given for the shortest possible duration.

This medication can cause liver damage, so individuals who consume more than 3 alcoholic beverages daily should consult with a physician or pharmacist before taking it. If any abnormal symptoms such as skin rashes or allergic reactions occur while taking this medication, discontinue use immediately and inform healthcare personnel. Dosage should be adhered to within the recommended range, as overdose may increase the risk of seizures. Particular caution is necessary when used in conjunction with other medications that may increase the risk of seizures. Patients with severe respiratory diseases should be administered this medication under the supervision of healthcare personnel, as it may suppress breathing. Taking this medication with alcohol or central nervous system depressants can lead to severe drowsiness, respiratory depression, or coma; therefore, concomitant use should be avoided. Patients with head injuries or increased intracranial pressure should exercise caution, as symptoms may worsen while taking this medication. This medication may cause psychological and physical dependence; careful monitoring for dependence is required during long-term use. Patients with compromised liver function or liver disease must consult a physician before taking this medication due to the risk of hepatotoxicity. Patients with specific genotypes may experience accelerated metabolism of this medication, increasing the risk of respiratory depression; caution is advised. This medication should not be given to children under 12 years of age or adolescents under 18 years who have undergone tonsillectomy or adenoidectomy. Patients with sleep apnea or hypoxia should be regularly evaluated for their condition, as symptoms may worsen while taking this medication. Elderly patients or those at risk of hyponatremia should monitor their serum sodium levels while taking this medication. Overdose may lead to severe side effects such as respiratory depression, seizures, and liver damage, requiring immediate emergency treatment. This medication may cause drowsiness or dizziness while driving or operating machinery, necessitating caution. Pregnant or nursing women should consult a physician before taking this medication, and it is safest to avoid it while breastfeeding. This medication interacts with several other drugs; if taking other medications, it is crucial to inform healthcare personnel. Keep out of reach of children and prevent misuse or accidental ingestion.

Serious side effects

Hives, severe swelling (angioedema), tightness in the chest, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, peeling skin, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), severe lethargy, sudden and severe headache, lightning headache, seizures, confusion of consciousness, visual disturbances, paralysis, urinary issues

Mild side effects

• Decreased appetite
• insomnia
• depression
• dizziness
• headache
• drowsiness
• nausea
• vomiting
• constipation
• dry mouth

This medication should be stored in a tightly sealed container to prevent air ingress and is best kept at room temperature between 1°C and 30°C. This helps maintain the effectiveness of the medication.

Appearance

Light yellow rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle